The University of Queensland, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, Brisbane, Qld 4072, Australia.
Curr Opin Microbiol. 2013 Jun;16(3):303-10. doi: 10.1016/j.mib.2013.03.002. Epub 2013 Mar 26.
Ilya Metchnikoff's use of starfish larvae to discover phagocytosis, and Bruno Lemaitre's and Jules Hoffmann's identification of host defence functions for Drosophila Toll provide compelling examples of the utility of model organisms for discovery of human innate immune pathways. Bruce Beutler's mapping of lipopolysaccharide non-responsiveness in C3H/HeJ mice to the Toll-like Receptor 4 gene similarly highlights the power of the mouse as a model. Models have limitations however, and characterising the functional relevance of human innate immune responses not conserved in the mouse presents both a challenge and an opportunity. Here we review differences between human and mouse Toll-like Receptors and inflammasome-forming Nod-like Receptors in repertoire, regulation and function, highlighting the significance of these differences for human innate immunity.
伊利亚·梅奇尼科夫(Ilya Metchnikoff)利用海星幼虫发现吞噬作用,布鲁诺·拉梅特(Bruno Lemaitre)和朱尔斯·霍夫曼(Jules Hoffmann)鉴定出果蝇 Toll 的宿主防御功能,这些都是利用模式生物发现人类先天免疫途径的有力例证。布鲁斯·贝特勒(Bruce Beutler)将 C3H/HeJ 小鼠对脂多糖的无反应性映射到 Toll 样受体 4 基因上,同样突出了小鼠作为模型的优势。然而,模型也有其局限性,并且要确定在小鼠中未保守的人类先天免疫反应的功能相关性,既是挑战也是机遇。在这里,我们综述了人类和小鼠 Toll 样受体以及炎性小体形成的 Nod 样受体在组成、调控和功能上的差异,强调了这些差异对人类先天免疫的重要性。